Articles written by Lisa Phillips:

Tenet Sells Struggling Philly Hospitals for $170 Million

Hospital deals are hopping in Philadelphia, this week. Last week, we reported on the merger of UPMC and PinnacleHealth, which brought Pittsburgh-based UPMC into the south central part of the state, where PinnacleHealth is strong. Now Tenet Healthcare (NYSE: THC) is selling two Philadelphia-based hospitals and other related operations to a new subsidiary of Paladin […]

PE Firms Target Behavioral Health, Eating Disorder Programs

Behavioral health care has never been a particularly active sector, but deal volume has increased year-over-year between 2010 and 2016, growing 412% in that time. And there’s a good chance that 2017 will continue this trend. Through August 30, 32 behavioral health care deals have been announced, up 7% compared with the same period last […]

Gilead Buys Kite Pharma to Diversify Portfolio

Gilead Sciences, Inc. (NASDAQ: GILD) finally found a target worth pursuing. The pharmaceutical company, perhaps best known for its high-priced hepatitis-C drugs, Harvoni and Solvadi, placed its bets on Kite Pharma, Inc. (NASDAQ: KITE), hoping to cash in on the biotech’s promising technology for fighting cancer.

UPMC and PinnacleHealth Team Up

PinnacleHealth System wasted little time after the Federal Trade Commission blocked its merger with Penn State Hershey Medical Center in 2016. Since then, the central Pennsylvania system has announced the acquisition of five hospitals, with a total of 720 beds. Now, it’s the target in another in-state merger deal.

MedEquities Trust Enters the Behavioral Health Sector

Real estate investment trusts (REITs) are back in action in the Behavioral Health Care sector. Last April we reported on Care Capital Properties (NYSE: CCP) $380 million deal for six inpatient facilities owned by Signature Healthcare Services LLC (dba Aurora Behavioral Health). Early in August, MedEquities Realty Trust (NYSE: MRT) made its first move into […]

PE Firms Line Up for Pharmaceutical Targets

Although pharmaceutical M&A has declined sharply over the past year, there has been an uptick in financial buyer activity in the sector in the first eight months of 2017. We don’t typically see a lot of financial buyers in this space, since they are easily outbid by strategic buyers that have the advantage of easy […]